Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

222 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Regeneron Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024
Regeneron Pharmaceuticals 1Q Revenue Declines Amid Lower EYLEA Sales
DJ
Regeneron Reports First Quarter 2024 Financial and Operating Results
GL
Transcript : Regeneron Pharmaceuticals, Inc., Q4 2023 Earnings Call, Feb 02, 2024
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
GL
Regeneron Named on Dow Jones Sustainability World Index for Fifth Consecutive Year
GL
Transcript : Regeneron Pharmaceuticals, Inc., Q3 2023 Earnings Call, Nov 02, 2023
Regeneron Reports Third Quarter 2023 Financial and Operating Results
GL
Regeneron Completes Acquisition of Decibel Therapeutics, Adding Promising Gene Therapy Programs for Hearing Loss
GL
Regeneron says CFO Landry to retire in February
RE
Regeneron Provides Update on Planned Chief Financial Officer Transition
GL
Regeneron Announces Updates to Board of Directors
GL
Regeneron Announces Agreement with BARDA Supporting Development of Next-Generation Antibody Therapy for COVID-19 Prevention
GL
Transcript : Regeneron Pharmaceuticals, Inc., Q2 2023 Earnings Call, Aug 03, 2023
Regeneron Reports Second Quarter 2023 Financial and Operating Results
GL
Regeneron Pharmaceuticals : Q1 2023 Earnings Conference Call Transcript
PU
Regeneron Applauds Supreme Court’s Unanimous Opinion Striking Down Amgen’s PCSK9 Patent Claims and Supporting Scientific Innovation
GL
Transcript : Regeneron Pharmaceuticals, Inc., Q1 2023 Earnings Call, May 04, 2023
Regeneron Reports First Quarter 2023 Financial and Operating Results
GL
Regeneron Pharmaceuticals Chairman P. Roy Vagelos to Retire
DJ
Regeneron Pharmaceuticals, Inc. Announces Management Changes
CI
Regeneron Announces Retirement of Board Chair, Dr. P. Roy Vagelos, Accomplished Physician-Businessman and Industry Luminary
GL
Students Win More Than $1.8 Million at 2023 Regeneron Science Talent Search for Remarkable Scientific Research on RNA Molecule Structure, Media Bias, and Diagnostics for Pediatric Heart Disease
GL
Transcript : Regeneron Pharmaceuticals, Inc., Q4 2022 Earnings Call, Feb 03, 2023
Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
GL
Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
GL
Top 40 High School Scientists Selected as Finalists in the Regeneron Science Talent Search, the Nation's Oldest and Most Prestigious Science and Math Competition
PR
Top 40 High School Scientists Selected as Finalists in the Regeneron Science Talent Search, the Nation’s Oldest and Most Prestigious Science and Math Competition
GL
Regeneron Named on Dow Jones Sustainability World Index for Fourth Consecutive Year
PR
Transcript : Regeneron Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 03, 2022
Regeneron Reports Third Quarter 2022 Financial and Operating Results
PR
Transcript : Regeneron Pharmaceuticals, Inc., Q2 2022 Earnings Call, Aug 03, 2022
Regeneron Pharmaceuticals : Reports Second Quarter 2022 Financial and Operating Results - Form 8-K
PU
Regeneron Reports Second Quarter 2022 Financial and Operating Results
PR
Transcript : Regeneron Pharmaceuticals, Inc. - Special Call
Regeneron Strengthens Commitment to Oncology through Purchase of Sanofi's Stake in the Regeneron and Sanofi Collaboration on Libtayo® (cemiplimab), a PD-1 Inhibitor Approved for Multiple Forms of Cancer
PR
Regeneron Completes Acquisition of Checkmate Pharmaceuticals
PR
Transcript : Regeneron Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 04, 2022
Regeneron Reports First Quarter 2022 Financial and Operating Results
PR
Checkmate Pharmaceuticals : Joint Press Release, issued April 19, 2022 - Form 8-K
PU
Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types
PR
Students Win $1.8 Million at Regeneron Science Talent Search 2022 for Exceptional Research on Neutron Star--Black Hole Systems, Narrowband Radar, and Ribosome Movement in Protein Translation
PR
Regeneron Pharmaceuticals : Annual Report (Form 10-K)
PU
Regeneron Pharmaceuticals : Reports Fourth Quarter and Full Year 2021 Financial and Operating Results - Form 8-K
PU
Forty Accomplished Young Scientists Named Finalists in the 2022 Regeneron Science Talent Search
PR
Regeneron Listed on Dow Jones Sustainability World Index for Third Consecutive Year
PR
Transcript : Regeneron Pharmaceuticals, Inc., Q3 2021 Earnings Call, Nov 04, 2021
Regeneron Reports Third Quarter 2021 Financial and Operating Results - Form 8-K
PU
Regeneron Pharmaceuticals : U.S. to buy 1.4 mln additional doses of Regeneron's COVID-19 therapy
RE
Regeneron Pharmaceuticals : Announces New U.S. Government Agreement to Purchase Additional Doses of REGEN-COV™ (casirivimab and imdevimab) Antibody Cocktail
PR
No results for this search
  1. Stock Market
  2. Advanced search
  3. Leonard Schleifer
  4. News